CCL5 of glioma-associated microglia/macrophages regulates glioma migration and invasion via calcium-dependent matrix metalloproteinase-2.
Glioma-associated myeloid (GAM) infiltrates are comprised of macrophages of peripheral origin and brain-intrinsic microglia, which support tumor progression. CCL5 is an inflammatory mediator produced by immune cells and is involved in tumor growth and migration in several cancers including glioma. However, the mechanisms detailing how CCL5 facilitates glioma invasion remain largely unresolved. Glioma migration and invasion were determined by wound healing, transwell assay, and 3D µ-slide chemotaxis assay. The expression levels of CCL5, CD68, MMP-2, p-CaMKII, p-Akt, and p-PYK2 were determined by cytokine array, q-PCR, western blot, or IHC. Zymography and intracellular calcium assays were used to analyze MMP-2 activity and intracellular calcium levels, respectively. CCL5 modulated the migratory and invasive activities of human glioma cells in association with MMP-2 expression. In response to CCL5, glioma cells underwent a synchronized increase in intracellular calcium levels, p-CaMKII and p-Akt expression levels. CCL5-directed glioma invasion and increases in MMP-2 were suppressed after inhibition of p-CaMKII. Glioma cells tended to migrate toward GM-CSF-activated GAM conditioned media in which CCL5 was abundant. This homing effect was associated with MMP-2 upregulation, and could be ameliorated either by controlling intracellular and extracellular calcium levels or by CCL5 antagonism. Clinical results also revealed the associations between CCL5 and GAM activation. Our results suggest that modulation of glioma CaMKII may restrict the effect of CCL5 on glioma invasion and could be a potential therapeutic target for alleviating glioma growth.